We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

RISK FACTORS FOR ANASTOMOTIC LEAKAGE FOLLOWING TOTAL OR SUBTOTAL COLECTOMY (RIALTCOT) (RIALTCOT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04512326
Recruitment Status : Unknown
Verified August 2020 by Juan Ocaña Jiménez, Hospital Universitario Ramon y Cajal.
Recruitment status was:  Enrolling by invitation
First Posted : August 13, 2020
Last Update Posted : August 13, 2020
Sponsor:
Information provided by (Responsible Party):
Juan Ocaña Jiménez, Hospital Universitario Ramon y Cajal

Brief Summary:

Higher anastomotic leakage (AL) rate is reported after ileosigmoid (ISA) or ileorectal anastomosis (IRA) in total or subtotal colectomy (TSC) compared to colonic or colorectal anastomosis. An AL reduction in these cases may improve short and long terms outcomes significantly. Current evidence remains insufficient to assess AL risk after TSC, based on single-center studies or small cases series. The investigators aim to analyse and identify potential risk factors to AL following TSC and ISA or IRA, both preoperative and intraoperative in order to prevent surgical complications.

The study is set up as a retrospective multicentre observational study. Inclusion criteria are patients (1) over 18 years old, (2) underwent restorative TSC with ISA or IRA anastomosis, (3) with/without loop ileostomy (4) between 2013-2019. Exclusion criteria are: (1) non-restorative TSC, (2) previous colorectal resection, (3) deferred anastomosis in trauma surgery and (4) other surgical resection in the same procedure.

AL will be defined as a defect of the integrity of the intestinal wall at the anastomotic site leading to a communication of the intra and extraluminal or a pelvic abscess adjacent to the anastomosis according to the definition set by de International Study Group of Rectal Cancer. AL requiring no active therapeutic intervention will be classified as Grade A. AL requiring active therapeutic intervention (antibiotics and percutaneous drainage) but manageable without relaparotomy will be classified as Grade B and AL requiring re-intervention were classified as Grade C.

Multivariable logistic regression model will be used in order to assess potential AL risk factors. p value <0,05 will be consider to indicate statistical significance.

Primary outcome is to assess potential risk factors to AL after restorative (ISA or IRA) TSC. Secondary outcomes are to identify risk factors to associated postoperative morbidity, mortality and re-admissions.

Data will be collected in each participating center enrolled in the study by the assigned principal investigator, confidentially and codified. Data will be sent to the study principal investigator. Database, patients code and email address will be provided at the study inclusion.


Condition or disease Intervention/treatment
Total Colectomy Subtotal Colectomy Procedure: Total or Subtotal colectomy

Detailed Description:

Ileorectal (IRA) or ileosigmoid anastomosis (ISA) following Total or Subtotal Colectomy (TSC) are frequently performed in inflammatory bowel disease (IBD) (Crohn´s disease, ulcerative colitis and indeterminate colitis), familiar adenomatous polyposis or colonic polyposis syndromes and colorectal cancer (CRC). TSC is less frequently performed in refractory constipation and ischemic colitis.

Anastomotic leakage (AL) is a significant complication associate with increased mortality, reoperation and derivative morbidity and is also related to poor long term outcomes in oncological resections. Although, the formation of IRA or ISA is anatomically easy to performed, pelvic dissection is not mandatory, there is no tension at the anastomosis and a blood supply is theoretically ensured, higher AL risk is reported after IRA or ISA (6.5-21%) compared to colonic or colorectal anastomosis with lower AL rate, mainly under 15%. Regardless of the indication, similar AL rates are seen after TSC in IBD (4-12%), polyposis (20%) and colon cancer (6-21%). Reducing AL rates might improve short, long term and functional outcomes after IRA or ISA There is not a wide evidence about determinants for AL following colectomy with IRA or ISA.

The impact of the anastomosis (ISA or ISA) on AL is controversial with no findings any in the most recent studies. Great number of studies have been published about risk factors for AL after colectomy, but the majority are focused in colorectal cancer patients. IRA or ISA results after TSC are mixed with other anastomosis sites and the reported results are hardly clear and conclusive.

For this reason, The investigators aim to assess potential risk factors to AL in restorative TSC, including every surgical main reason.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: RISK FACTORS FOR ANASTOMOTIC LEAKAGE FOLLOWING TOTAL OR SUBTOTAL COLECTOMY (RIALTCOT)
Actual Study Start Date : August 10, 2020
Estimated Primary Completion Date : June 30, 2021
Estimated Study Completion Date : November 30, 2021

Group/Cohort Intervention/treatment
Total or subtotal colectomy
Total or subtotal colectomy with ileorectal or ileosigmoid anastomosis
Procedure: Total or Subtotal colectomy
Total or subtotal colectomy (emergent or elective) with primary anastomosis (ileorectal or ileosigmoid)




Primary Outcome Measures :
  1. Anastomotic Leakage [ Time Frame: 90 days postoperatively ]
    AL requiring no active therapeutic intervention will be classified as Grade A. AL requiring active therapeutic intervention (antibiotics and percutaneous drainage) but manageable without relaparotomy will be classified as Grade B and AL requiring re-intervention will be classified as Grade C


Secondary Outcome Measures :
  1. Risk factors associated to postoperative morbidity [ Time Frame: 90 days postoperatively ]
    Morbidity by Clavien-Dindo scale

  2. Risk factors associated to mortality [ Time Frame: 90 days postoperatively ]
    Mortality in postoperatively

  3. Risk factors associated to re-admissions. [ Time Frame: 90 days postoperatively ]
    Re-admissions after discharge within 90 days postoperatively



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients underwent total or subtotal colectomy with primary anastomosis
Criteria

Inclusion Criteria:

  • (1) over 18 years old
  • (2) underwent restorative TSC with ISA or IRA anastomosis (emergent or elective)
  • (3) with/without loop ileostomy
  • (4) between 2013-2019

Exclusion Criteria:

  • (1) non-restorative TSC
  • (2) previous colorectal resection
  • (3) deferred anastomosis in trauma surgery and
  • (4) other surgical resection in the same procedure.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04512326


Locations
Layout table for location information
Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain, 28034
Sponsors and Collaborators
Hospital Universitario Ramon y Cajal
Investigators
Layout table for investigator information
Principal Investigator: Juan Ocaña, MD H.U Ramon y Cajal
Publications of Results:

Other Publications:
Layout table for additonal information
Responsible Party: Juan Ocaña Jiménez, Principal Investigator, Hospital Universitario Ramon y Cajal
ClinicalTrials.gov Identifier: NCT04512326    
Other Study ID Numbers: 212/20
First Posted: August 13, 2020    Key Record Dates
Last Update Posted: August 13, 2020
Last Verified: August 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Juan Ocaña Jiménez, Hospital Universitario Ramon y Cajal:
Total colectomy
Subtotal colectomy
Ileorectal anastomosis
Ileosigmoid anastomosis
Anastomotic leakage
Additional relevant MeSH terms:
Layout table for MeSH terms
Anastomotic Leak
Postoperative Complications
Pathologic Processes